A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
A phase 1/2 trial of QLC5508, QL1706, Carboplatin, Cisplatin, QL2107 and Fluorouracil (5-FU) in advanced solid tumours, run by Qilu Pharmaceutical Co., Ltd., now recruiting.
Overview
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07256782 by Qilu Pharmaceutical Co., Ltd., with 444 participants planned, started 2025-10-24 and due to reach its primary completion in 2026-10. Interventions recorded: QLC5508, QL1706, Cisplatin/ Carboplatin, QL2107, Paclitaxel and 5-fluorouracil (5-FU).
Similar pages
not linked directly; found by shared links- TrialA Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Shares QL2107, Qilu Pharmaceutical, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialStudy of MHB088C for Patients With Advanced Solid Malignant Tumors
Shares QLC5508, Qilu Pharmaceutical, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Shares Cisplatin, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Shares QLC5508, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialGM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
Shares Qilu Pharmaceutical, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Shares Cisplatin, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialTo Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
Shares Cisplatin, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Shares Cisplatin, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.